Amylyx Pharmaceuticals Inc. (AMLX) Statistics & Valuation Metrics - Stocknear

Amylyx Pharmaceuticals In...

NASDAQ: AMLX · Real-Time Price · USD
14.52
0.70 (5.07%)
At close: Sep 26, 2025, 3:59 PM
14.80
1.93%
After-hours: Sep 26, 2025, 06:34 PM EDT

Amylyx Pharmaceuticals Statistics

Share Statistics

Amylyx Pharmaceuticals has 89.16M shares outstanding. The number of shares has increased by 30.93% in one year.

89.16M
30.93%
0.61%
81.29%
58.62M
1,466
0.08%

Short Selling Information

The latest short interest is 8.77M, so 8.23% of the outstanding shares have been sold short.

8.77M
8.23%
8.92%
3.88

Valuation Ratios

The PE ratio is -0.85 and the forward PE ratio is -9.8. Amylyx Pharmaceuticals's PEG ratio is 0.

-0.85
-9.8
2.95
16057.9
1.56
-1.53
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Amylyx Pharmaceuticals.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 6.67, with a Debt / Equity ratio of 0.01.

6.67
6.67
0.01
-0.01
-0.01
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$710.33K
$-2.45M
123
0.45
n/a

Taxes

-393K
0.13%

Stock Price Statistics

The stock price has increased by 371.43% in the last 52 weeks. The beta is -0.44, so Amylyx Pharmaceuticals's price volatility has been lower than the market average.

-0.44
371.43%
9.71
5.78
87.46
1,813,292

Income Statement

In the last 12 months, Amylyx Pharmaceuticals had revenue of 87.37M and earned -301.74M in profits. Earnings per share was -4.43.

87.37M
-37.26M
-314.73M
-301.74M
-290.98M
-291.88M
-4.43
Full Income Statement

Balance Sheet

The company has 77.39M in cash and 1.98M in debt, giving a net cash position of 75.41M.

77.39M
1.98M
75.41M
-606.69M
194.6M
165.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -167.65M and capital expenditures -157K, giving a free cash flow of -167.8M.

-167.65M
-157K
-167.8M
-2.46
Full Cash Flow Statement

Margins

Gross margin is -42.65%, with operating and profit margins of -360.22% and -345.36%.

-42.65%
-360.22%
-345.81%
-345.36%
-333.03%
-360.22%
-192.06%

Dividends & Yields

AMLX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for AMLX is $12, which is -17.4% lower than the current price. The consensus rating is "Buy".

$12
-17.4%
Buy
7
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

16.47
2